Just 3.2% of adult smokers with peripheral artery disease (PAD) were prescribed the smoking-cessation drug varenicline, according to a new study. Smoking is the leading modifiable risk factor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results